{"id":4552,"date":"2014-07-30T21:39:45","date_gmt":"2014-07-30T21:39:45","guid":{"rendered":"http:\/\/www.scienceofdme.org\/?p=4552"},"modified":"2014-08-01T16:49:48","modified_gmt":"2014-08-01T16:49:48","slug":"fda-approves-anti-vegf-agent-aflibercept-for-treating-diabetic-macular-edema-dme","status":"publish","type":"post","link":"https:\/\/www.scienceofdme.org\/de\/fda-approves-anti-vegf-agent-aflibercept-for-treating-diabetic-macular-edema-dme\/","title":{"rendered":"(English) FDA approves anti-VEGF agent aflibercept for treating Diabetic Macular Edema (DME)"},"content":{"rendered":"<p><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.scienceofdme.org\/de\/wp-json\/wp\/v2\/posts\/4552"}],"collection":[{"href":"https:\/\/www.scienceofdme.org\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scienceofdme.org\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scienceofdme.org\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scienceofdme.org\/de\/wp-json\/wp\/v2\/comments?post=4552"}],"version-history":[{"count":3,"href":"https:\/\/www.scienceofdme.org\/de\/wp-json\/wp\/v2\/posts\/4552\/revisions"}],"predecessor-version":[{"id":4555,"href":"https:\/\/www.scienceofdme.org\/de\/wp-json\/wp\/v2\/posts\/4552\/revisions\/4555"}],"wp:attachment":[{"href":"https:\/\/www.scienceofdme.org\/de\/wp-json\/wp\/v2\/media?parent=4552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scienceofdme.org\/de\/wp-json\/wp\/v2\/categories?post=4552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scienceofdme.org\/de\/wp-json\/wp\/v2\/tags?post=4552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}